Log in to save to my catalogue

Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor

Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_18bf94a3ea2d4e32b5861a62e60c62a8

Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor

About this item

Full title

Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor

Publisher

London: Nature Publishing Group UK

Journal title

EMBO molecular medicine, 2021-02, Vol.13 (2), p.e12640-n/a

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Rhabdoid tumor (RT) is a pediatric cancer characterized by the inactivation of SMARCB1, a subunit of the SWI/SNF chromatin remodeling complex. Although this deletion is the known oncogenic driver, there are limited effective therapeutic options for these patients. Here we use unbiased screening of cell line panels to identify a heightened sensitivi...

Alternative Titles

Full title

Mithramycin induces promoter reprogramming and differentiation of rhabdoid tumor

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_18bf94a3ea2d4e32b5861a62e60c62a8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_18bf94a3ea2d4e32b5861a62e60c62a8

Other Identifiers

ISSN

1757-4676

E-ISSN

1757-4684

DOI

10.15252/emmm.202012640

How to access this item